http://www.fpnotebook.com/

Pharmaceutical RepresentativesAka: Drug Reps, Prescribing Costs

Studies
1. Evaluation of 446 physicians surveyed
  1. Higher prescribing cost risks
    1. Pharmaceutical representative exposure
    2. Group practice setting
  2. References
    1. Caudill (1996) Arch Fam Med 5:201
2. Direct drug advertising to healthcare consumers
  1. Appears to increase sale of drugs
  2. May result in appropriate prescribing practices
  3. Mintzes (2002) BMJ 324:278

Navigation Tree

Please see the Terms and Conditions. Please also see the privacy statement regarding advertising on this page. Although access to this page is not restricted, the information found here is intended for use by medical providers. Patients should address specific medical concerns with their physicians.

This page was written by Scott Moses, MD. This page was last revised before 5/10/08, prior to consistent tracking of revision date. This page was last published on 6/1/2008. Please send comments and questions to the editor. Contact information may be found on the page About the Family Practice Notebook. These pages are best viewed with Microsoft Internet Explorer 6.0.

Pharmacology Book

Miscellaneous

Prevention Chapter related topics

http://www.fpnotebook.com/

Pharmaceutical RepresentativesAka: Drug Reps, Prescribing Costs

Navigation Tree